HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Draft CSIA Bill “Reproduces” TSCA, Endangers State Programs – Critics

This article was originally published in The Rose Sheet

Executive Summary

Bipartisan bill proposed to update U.S. chemicals regulation – the Chemical Safety Improvement Act – “was written to suit the chemicals industry” and would actually be a step backward from the status quo under TSCA, the Environmental Working Group suggests. Other NGOs and legal experts voiced similar criticisms in letters to key Senate members.

You may also be interested in...



IFRA North America Gears Up For “Active” Year On Legislative Front

Jennifer Abril, president of International Fragrance Association North America, identifies top priorities for the group in what is expected to be an active year for legislative and regulatory efforts impacting fragrance.

Industry Group Sustainability Report Identifies Challenges

American Cleaning Institute releases 2013 Sustainability Report, promoting efforts of members including Colgate-Palmolive and Church & Dwight in reaching sustainability goals, while also addressing sustainability challenges.

People In Brief

Longtime public-health champion Sen. Frank Lautenberg, D-N.J., passes at the age of 89. More people news.

Related Content

Latest News
See All
UsernamePublicRestriction

Register

RS018589

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel